Eisai Co., Ltd. (4523)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 07, 2025

$29.69

P/E Ratio

21.79

Market Cap

$8.37B

Description
Add to research

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Metrics
Add to research

Overview

  • HQTokyo, TY
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • Ticker4523
  • Price$29.692499+0.64%

Trading Information

  • Market cap$8.37B
  • Float85.78%
  • Average Daily Volume (1m)1,492,475
  • Average Daily Volume (3m)1,574,934
  • EPS$206.83

Company

  • Revenue$791.66B
  • Rev growth (1yr)21.63%
  • Net income$23.79B
  • Gross margin78.75%
  • EBITDA margin14.88%
  • EBITDA$32.17B
  • EV$1.17T
  • EV/Revenue1.48
  • P/E21.79
  • P/S1.61
  • P/B1.46
  • Debt/Equity25.09
Documents
Add to research